Advertisement

Topics

Imgenex Corp Company Profile

21:57 EST 11th December 2018 | BioPortfolio

Imgenex Corp. develops and commercializes novel reagents for the scientific study of human biology and disease and for the production of new diagnostic assays and potential therapies of such diseases. These novel reagents include antibodies, gene and protein expression systems, and arrays of various cells and tissues for use in studies of functional genomics. Areas of biological interest at Imgenex include cancer, apoptosis (programmed cell death), molecular signaling pathways, cellular aging, and metabolic and infectious diseases

Location

11175 Flintkote Avenue, Suite E
San Diego
California
92121
United States of America

Contact

Phone: 1-858-642-0978
Fax: 1-858-642-0937
Email: info@imgenex.com


News Articles [87 Associated News Articles listed on BioPortfolio]

CORRECTION from Source -- Emblem Corp.

TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- In Emblem’s Q2 release issued 22-Aug-2018 by Emblem Corp. over GlobeNewswire, we are advised by the company that corrections were made to the Adjusted E...

GTX Corp Announces New GPS Take-Along World Tracker for $89.00

LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announced toda...

Emblem Corp. announces new board appointments

TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi ...

GTX Corp Engages Doost, Inc. to Open Retail Channels

LOS ANGELES, July 19, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology,...

RMMI Corp. Completes Initial Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. CA...

GTX Corp Announces Update on Corporate Strategic Plan

LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology,...

Scythian Biosciences Announces Name Change to SOL Global Investments Corp.

TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Compa...

Helix Biopharma Corp. Closes First Tranche of Private Placement

RICHMOND HILL, Ontario, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candi...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

CORP: Partitional Calorimetry.

For thermal physiologists, calorimetry is an important methodological tool to assess human heat balance during heat or cold exposures. A whole-body direct calorimeter remains the gold standard instrum...

CORP: assessments of upper- and lower-limb muscle strength and voluntary activation in humans.

Muscle strength - the maximal force generating capacity of a muscle or group of muscles - is regularly assessed in physiological experiments and clinical trials. An understanding of the expected varia...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Companies [43 Associated Companies listed on BioPortfolio]

Imgenex Corp

Imgenex Corp. develops and commercializes novel reagents for the scientific study of human biology and disease and for the production of new diagnostic assays and potential therapies of such diseases....

Imgenex

Our goal is to provide quality reagents at affordable price for biomedical research. We also provide custom services for baculovirus, bacterial, and mammalian gene expression. Recently, we have introd...

NORLOFF COMPUTER CORP

Nil

ATLANTIS DRUG CORP

Nil

Precision Engineered Products LLC

More Information about "Imgenex Corp" on BioPortfolio

We have published hundreds of Imgenex Corp news stories on BioPortfolio along with dozens of Imgenex Corp Clinical Trials and PubMed Articles about Imgenex Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Imgenex Corp Companies in our database. You can also find out about relevant Imgenex Corp Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record